CLEVELAND, July 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory ...

Sotera Health (NASDAQ:SHC) announced the launch of a secondary offering of 25M shares of its common stock, par value $0.01 per share. All 25M shares are being offered for sale by certain ...

Key Insights The projected fair value for Sotera Health is US$19.48 based on 2 Stage Free Cash Flow to Equity Current share price of US$11.99 suggests Sotera Health is potentially 38% undervalued ...

Sotera Health Company is down 5.1% since the beginning of the year, and at $12.92 per share, it is trading 23.6% below its 52-week high of $16.91 from September 2024. Investors who bought $1,000 ...

The company also told investors that it will record a $408 million settlement for 2022. Sotera’s stock has plunged 60.1% over the past year, while the broader S&P 500 SPX is down 16.8%.

SHC Price Action: Sotera has a 52-week high of $24.90 and a 52-week low of $5.78. The stock was up 33.4% at $8.03 at time of publication, according to Benzinga Pro. Photo: Daniel Bone from Pixabay.

According to S&P, Sotera violated what’s known as a debt leverage covenant. Though the ratings service would not provide details about the requirement, these types of agreements typically ...